PRJNA691120
Low-coverage sequencing of urine sediment DNA for detection of copy number aberrations in bladder cancer
Low-coverage whole-genome sequencing method for the detection of CNAs in urine sediment DNA from patients with bladder cancer, provides a promising method for noninvasive diagnosis of bladder cancer, but still needs further verification in a larger sample size.